PAVmed (PAVM) Preferred Shares (2017 - 2026)

PAVmed has reported Preferred Shares for 10 years, with the latest figure at $3.8 million in Q2 2026.

• On a quarterly basis, Preferred Shares fell 81.74% year-over-year to $3.8 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 81.74% decrease from a year earlier, with the FY2025 full-year figure at $21.0 million, up 533.69% from the prior year.
• Preferred Shares was $3.8 million for Q2 2026 at PAVmed, down from $21.0 million in the prior quarter.
• The five-year high for Preferred Shares was $22.9 million in Q1 2025, with the low at $2.5 million in Q1 2022.
• Average Preferred Shares over 5 years is $7.5 million, with a median of $3.0 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Preferred Shares jumped 644.97% in 2025, then tumbled 81.74% in 2026.
• Over 5 years, Preferred Shares stood at $2.7 million in 2022, then climbed by 11.06% to $3.0 million in 2023, then gained by 10.79% to $3.3 million in 2024, then soared by 533.69% to $21.0 million in 2025, then slumped by 81.68% to $3.8 million in 2026.
• The last three Preferred Shares figures came in at $3.8 million (Q2 2026), $21.0 million (Q4 2025), and $20.5 million (Q3 2025), per Business Quant data.